GB202004335D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB202004335D0
GB202004335D0 GBGB2004335.2A GB202004335A GB202004335D0 GB 202004335 D0 GB202004335 D0 GB 202004335D0 GB 202004335 A GB202004335 A GB 202004335A GB 202004335 D0 GB202004335 D0 GB 202004335D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2004335.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inflazome Ltd
Original Assignee
Inflazome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inflazome Ltd filed Critical Inflazome Ltd
Priority to GBGB2004335.2A priority Critical patent/GB202004335D0/en
Publication of GB202004335D0 publication Critical patent/GB202004335D0/en
Priority to JP2022525955A priority patent/JP2023501334A/en
Priority to CN202080074261.1A priority patent/CN114599356A/en
Priority to EP20803798.6A priority patent/EP4054564A1/en
Priority to US17/775,230 priority patent/US20220409585A1/en
Priority to PCT/EP2020/081290 priority patent/WO2021089782A1/en
Ceased legal-status Critical Current

Links

GBGB2004335.2A 2019-11-07 2020-03-25 Novel treatment Ceased GB202004335D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2004335.2A GB202004335D0 (en) 2020-03-25 2020-03-25 Novel treatment
JP2022525955A JP2023501334A (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory diseases
CN202080074261.1A CN114599356A (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
EP20803798.6A EP4054564A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
US17/775,230 US20220409585A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders
PCT/EP2020/081290 WO2021089782A1 (en) 2019-11-07 2020-11-06 Treatment of autoinflammatory disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2004335.2A GB202004335D0 (en) 2020-03-25 2020-03-25 Novel treatment

Publications (1)

Publication Number Publication Date
GB202004335D0 true GB202004335D0 (en) 2020-05-06

Family

ID=70546657

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2004335.2A Ceased GB202004335D0 (en) 2019-11-07 2020-03-25 Novel treatment

Country Status (1)

Country Link
GB (1) GB202004335D0 (en)

Similar Documents

Publication Publication Date Title
GB202108224D0 (en) Treatment
GB202116743D0 (en) Treatment
GB202103122D0 (en) Treatment
GB202016058D0 (en) Therapeautic treatment
GB202003722D0 (en) Treatment
GB202002711D0 (en) Treatment
GB202006564D0 (en) Novel treatment
GB202004315D0 (en) Novel treatment
GB202004335D0 (en) Novel treatment
GB202003643D0 (en) Novel treatment
GB202003647D0 (en) Novel treatment
GB202003645D0 (en) Novel treatment
GB202003642D0 (en) Novel treatment
GB202000808D0 (en) Novel treatment
GB202000810D0 (en) Novel treatment
GB202000806D0 (en) Novel treatment
GB202000805D0 (en) Novel treatment
IL312981A (en) Treatment
GB202114373D0 (en) Treatment
GB202109812D0 (en) Treatment
GB202109815D0 (en) Treatment
GB202104666D0 (en) COVID-19 treatment
GB202104416D0 (en) Treatment reginmens
GB202103957D0 (en) Treatment
GB202102488D0 (en) Treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)